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Background: Cancer multidisciplinary teams (MDTs) are established in many countries but little is known about how well
they function. A core activity is regular MDT meetings (MDMs) where treatment recommendations are agreed. A mixed
methods descriptive study was conducted to develop and test quality criteria for observational assessment of MDM
performance calibrated against consensus from over 2000 MDT members about the “characteristics of an effective MDT”.
Methods: Eighteen of the 86 ‘Characteristics of Effective MDTs’ were considered relevant and feasible to observe. They
collated to 15 aspects of MDT working covering four domains: the team (e.g. attendance, chairing, teamworking);
infrastructure for meetings (venue, equipment); meeting organisation and logistics; and patient-centred clinical
decision-making (patient-centredness, clarity of recommendations). Criteria for rating each characteristic from ‘very poor’
to ‘very good’ were derived from literature review, observing MDMs and expert input. Criteria were applied to 10 bowel
cancer MDTs to assess acceptability and measure variation between and within teams. Feasibility and inter-rater
reliability was assessed by comparing three observers.
Results: Observational assessment was acceptable to teams and feasible to implement. Total scores from 29 to 50 (out
of 58) highlighted wide diversity in quality between teams. Eight teams were rated either ‘very good/good’ or ‘very
poor/poor’ for at least three domains demonstrating some internal consistency. ‘Very good’ ratings were most likely for
attendance and administrative preparation, and least likely for patient-centredness of decision-making and prioritisation
of complex cases. All except two characteristics had intra-class correlations of ≥0.50.
Conclusions: This observational tool (MDT-OARS) may contribute to the assessment of MDT performance. Further
testing to confirm validity and reliability is required.
Keywords: Cancer, Multidisciplinary Communication, Interprofessional relations, Observation, Quality Indicators Health
Care, Decision-making, Leadership, Health resourcesBackground
Cancer multidisciplinary teams (MDTs) are well established
in the UK and other countries as a core mechanism for im-
proving patient outcomes. A core activity is regular MDT
meetings (MDMs), held weekly for most tumour types,
which brings together all relevant health professionals to
discuss and agree patient treatment plans.
The benefits of MDTs in relation to improved adherence
to evidence-based guidelines, better treatment decisions,
and association with better clinical outcomes including sur-
vival have been well documented [1,2]. Nevertheless MDTs
are a very expensive resource and we know little about how* Correspondence: cath.taylor@kcl.ac.uk
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reproduction in any medium, provided the orwell they individually function. The UK national annual
cancer peer review programme provides a mandatory
mechanism for assessment of MDTs. MDTs have to show
their compliance with standards that are derived from
tumour-specific improving outcomes guidance (which is in
turn based on evidence and/or clinical consensus). Data
from the peer-review programme demonstrates wide vari-
ation between teams in adherence to standards [3,4]. The
standards encompass structural features of MDTs such as
team composition (having the required expertise) and
having protocols for referral and treatment but omit other
aspects of MDT functioning such as the quality of leader-
ship and chairing; teamwork (e.g. inclusiveness and mutual
respect); and the clinical decision-making process.
Evidence is accruing regarding the association between
process and outcomes in cancer MDTs [2]. The quality oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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MDT discussion in a range of tumour types [5-7]. The
quality of MDT recommendations relies upon considera-
tion of all relevant information. Failure to consider patient-
based information has been shown to be a major reason for
non-implementation of recommendations, either due to
being unacceptable to patients or clinically inappropriate
[8-11]. Moreover, non-implementation of MDT meeting
recommendations can have both clinical and financial con-
sequences if further discussion is required and treatment is
delayed. This is likely to require inclusive discussions in
MDT meetings but research has shown that cancer MDT
meetings may prioritise the medical model and place less
value on the contributions of non-medical members of the
team [12,13].
Robust assessment of the complex behaviours and activi-
ties in MDMs is likely to require mixed methods including
independent observation [14,15]. Observational measures
have been developed to assess teamwork in other health-
care teams, such as surgical teams [16,17]. To apply such
methods to MDTs first requires agreement about the opti-
mal MDT characteristics. Determining causal relationships
between teamworking and outcome is riddled with
methodological challenges, which may partly account for
the lack of empirical research regarding predictors of
effectiveness [1]. Nevertheless, consensus of opinion in a
recent UK national survey completed by over 2000 MDT
members [18] resulted in recommendations for MDT
working: ‘The characteristics of an effective MDT’ [19].
Eighty-six ‘characteristics of effectiveness’ are organised
within five domains: The Team; Infrastructure for meetings;
Meeting organisation and logistics; Clinical decision-
making; and Clinical governance. These characteristics pro-
vide a framework against which to develop objective criteria
for assessing the quality of teamworking in MDMs.
Aims
 To develop quality criteria for assessment of
characteristics observable in MDMs
 To conduct preliminary tests of their acceptability
with 10 bowel cancer teams, to include describing:
∘ the variation within and between teams
∘ the characteristics most/least likely to receive high
quality ratings
 To test inter-rater reliability and feasibilityMethods
Development of MDT-OARS (Observational Assessment
Rating Scale)
Each of the 86 ‘characteristics of effective MDTs’ [19]
was considered in turn for its relevance and feasibility
for independent observational measurement in MDTmeetings. Additional consideration was given to whether
the characteristics were already measured in national peer
review assessments, and priority was given to including
characteristics that did not overlap with peer review. In total
18 of the 86 characteristics were felt to be observable. Due
to overlap between characteristics these aggregated into 15
aspects of teamworking (Table 1).
Quality criteria for each characteristic were initially
informed by relevant literature, observation of MDMs in a
range of tumour types, and review of the survey data that
had informed the Characteristics [18]. These prototype
quality criteria were subsequently reviewed by an inde-
pendent panel consisting of a consultant radiologist,
oncologist and nurse with bowel cancer expertise as well
as a senior NHS cancer manager. The panel discussed the
potential variation in quality for each characteristic. Opti-
mal ratings were calibrated against the recommendations
in the Characteristics. Thresholds for lower quality per-
formance were based on consensual agreement about the
added value or detriment to MDT-working of variations to
the optimal rating. It was agreed that the variation in
quality for most characteristics would best be represented
on a four-point scale: very poor (1), poor (2), good (3) or
very good (4). Very poor/poor were merged for three
characteristics where it was felt that further categorisation
would lose value (Table 1).
Video-taped observation was proposed for rating be-
havioural characteristics such as chairing, teamwork and
decision-making, to enable multiple observers to rate iden-
tical footage and allow replay. To enhance the reliability of
behavioural ratings a case discussion proforma was deve-
loped for rating characteristics on a case-by-case basis prior
to being aggregated to an overall rating (Additional file 1).
Aggregation was a qualitative process for most characteris-
tics: forming global judgments on the rating that best
reflected performance based on notes taken for individual
cases. The only exception was patient centred care where
the rating was based on quantification of objective content.
This was because it would be necessary to know the patient
in order to value-judge this characteristic of effectiveness.
Rating is instead based on the frequency that patient-based
information is considered (Table 1). Aspects of team func-
tioning that could not easily be observed on a video-taped
recording and could be objectively described were rated on
the basis of notes and/or information collected by the
researcher at the time of the videotaped meeting. This
included attendance, the meeting agenda, meeting venue
and technology. The researcher who was present at the
meeting verified attendance information from the MDT
lead and/or MDT coordinator, obtained an anonymised
hard copy of the meeting agenda, and recorded information
about the meeting venue and technology on a study-specific
proforma (Additional file 2) to ensure systematic recording
of the detail required for assessing these criteria.
Table 1 MDT-OARS quality criteria and shortened manual for rating each of 15 observable characteristics of effective teamworking in MDT meetings
Characteristic
of effective
MDT working
Quality Criteria Quality of team working (score in brackets)
Very Poor Poor Good Very Good
The Team
Attendance Presence of relevant core
team members at the meeting
at least one core team member
(and their deputy) is not present
for the whole meeting
at least one core team member
(and deputy) is absent for
most of the meeting (≥3 cases)
at least one core team member
(and deputy) is absent for part
of the meeting (≤ 2 cases)
all core team members (or deputy)
present for whole meeting
(1) (2) (3) (4)
Leadership:
chairing of
meeting
• Keeps meeting to agenda
(i.e. moves onto next case)
Satisfies none of criteria Only satisfies 1–2 of criteria Satisfies 3 of criteria Evidence of all of the criteria
• Encourages overall participation
• Encourages focussed discussion
• Articulates recommendation (1) (2) (3) (4)
Teamworking
& culture
a) Inclusion of
relevant team
members
• All relevant core members
are actively and appropriately
involved
Satisfies 1/none of criteria Satisfies 2–4 of criteria Satisfies “all relevant core
members are actively and
appropriately involved” and at
least 3 other criteria
Satisfies all of the criteria
• Meeting not dominated
by 1-2 people
• Input/questions volunteered
and encouraged
• Contributions facilitate
decision-making and/or inform
discussion
• Consensus of decision-making (1) (2) (3) (4)
b) Team
Sociability
• Evidence of humour Satisfies none of the criteria Satisfies 1 of criteria Satisfies 2–3 of criteria Satisfies all of criteria
• Team appear relaxed with each
other
• Warm and supportive team
environment
• Friendly and cooperative
communicative style
(1) (2) (3) (4)
c) Mutual respect • Focussed attention Only satisfies 1 or none of Satisfies 2–3 of criteria Evidence of respect, Strong evidence of
• Respect for speaker criteria evidence of at least 4 respect in all/almost all
• No concurrent discussions criteria cases
• Asking and valuing relevant
contributions
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Table 1 MDT-OARS quality criteria and shortened manual for rating each of 15 observable characteristics of effective teamworking in MDT meetings
(Continued)
• General sense of politeness/
courtesy (inc mobile phone
etiquette)
(1) (2) (3) (4)
d) tension and
conflict
Not rated on the same scale – see bottom of table
Personal
development &
training
Observable communication of
research evidence and/or
instances of learning
No observable communication of
research evidence or instances of
learning
Minimal communication of research
evidence or instances of learning
Structured presentation of research
evidence and/or learning through
formal discussion (e.g. of audit findings
(1) (2) (3)
Infrastructure
for meetings
Meeting venue • Room size appropriate for number
of team members
Satisfies only 1 or none of criteria Satisfies 2 of the criteria Satisfies 3 of the criteria Satisfies all of the criteria
• Layout of chairs enables accessible
viewing of diagnostics
• Layout of room allows accessible
viewing of other team members
• All members seated on a chair
• Suitable venue in terms of location,
temperature, lighting etc
(1) (2) (3) (4)
Technology &
equipment
Availability of diagnostic equipment
to view and share images and
pathology with the team.
No radiology imaging facilities Light box available with hard
copy film
Current images available
digitally with facilities for
projecting/viewing images
Current images available digitally with
facilities for projecting/viewing images
and capability of accessing
retrospective images (e.g. use of PACS)
Availability of multiple screens
scores extra 1 point. Score out
of possible 9 is then standardised
onto 1-4 scale to give overall rating.
(1) (2) (3) (4)
No histopathology facilities Microscope Microscope with facilities for
projecting/viewing
specimen/biopsy
Microscope with facilities for projecting
and viewing specimen/biopsy and
accessing retrospective data
(1) (2) (3) (4)
Meeting
organisation
and logistics
Preparation
prior to meetings:
a) agenda Availability and content of agenda No available agenda Agenda, but limited info Comprehensive agenda
(1) (2) (3)
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Table 1 MDT-OARS quality criteria and shortened manual for rating each of 15 observable characteristics of effective teamworking in MDT meetings
(Continued)
b) prioritisation
of complex cases
Prioritisation of complex cases on
agenda to enable sufficient time for
their discussion
No attempt is made to order cases
in terms of complexity and an
inappropriate amount of time is
spent on cases (i.e. too much or
too little)
Some attempt is made to order
cases in terms of complexity
but an inappropriate amount
of time is spent discussing some
of the cases
Patient cases are discussed in a
clear order but time is used
inappropriately in some cases
Patient cases are discussed in a clear
order and an appropriate amount of
time is spent discussing each case
(1) (2) (3) (4)
Organisation/admin
during meetings:
a) patient notes Availability of patient notes No patient records available at
meeting
Some required past/current
reports not available
Hardcopy and all necessary
past/current reports available
Electronic access to patient notes and
all necessary past/current reports
available
(1) (2) (3) (4)
b) case
presentation
Comprehensiveness and coherence
of case presentation
Rambling; entirely reading from
notes; does not seem familiar
with patient
Some evidence of familiarity
with patient and info presented
in reasonable fashion
Comprehensive succinct coherent
presentation
(evidence of familiarity with patient and
findings)
(1) (2) (3)
Clinical decision
making
Patient centred
care
Includes mention of patient-based
information (e.g. demography; co-
morbidities; psycho-social or
supportive needs; patient wishes/
family preferences)
Patient-centred factors sufficiently
acknowledged in less than 20%
cases
Patient-centred factors
sufficiently
acknowledged in less than 50%
cases
Patient-centred factors
sufficiently acknowledged
in 50% + cases (but not all cases)
Patient-centred factors sufficiently
acknowledged in all cases
(1) (2) (3) (4)
Treatment plans Clarity of treatment plan Treatment plan not discernable Treatment plan communicated
verbally
Treatment plan communicated
verbally and recorded
Treatment plan communicated verbally,
recorded with a clearly articulated plan
regarding the next steps.
(1) (2) (3) (4)
Characteristic
of Effective
MDT-working
Quality Criteria Quality of team-working
(score in brackets)
Teamworking &
culture
severe and sustained conflict overt conflict un-sustained tension sustained tension un-sustained no tension
(−4) (−3) (−2) (−1) (0)
d) tension/
conflict
Extent of tension and/
or conflict observable in
the team
≥1clear example of conflict
observed which persists
throughout meeting
≥1clear example of conflict
observed does not persist
throughout meeting
≥1 instance of tension
observed which persists
throughout meeting
≥1 instance of tension
observed but does not
persist throughout
meeting
No tension
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performance
Ten bowel cancer teams volunteered to participate
(ascertained via their participation in another study
[20]). One MDM per team was filmed and observed
in-vivo. Quality was subsequently assessed using
completed case discussion proformas, the completed
in-vivo proforma and anonymised agenda (Table 1,
Additional files 1 and 2). Short structured interviews
were conducted with a range of members from each
team (including at minimum the MDT lead, MDT
coordinator and clinical nurse specialist) to determine
the impact of the observational method on the meet-
ing, and confirm attendance information.
Team members provided written informed consent
prior to the meeting being video-recorded and all pa-
tient discussions and agendas were anonymised. Eth-
ics approval was granted by the South East Multi-
Centre Research Ethics Committee and R & D ap-
proval was obtained from the relevant NHS Trust for
each MDT.Table 2 Quality of teamworking in 10 bowel cancer teams: un
Characteristic of effective
teamworking
Rating
scale 1 2 3
S
The Team
Attendance 1 to 4 4 4 3
Leadership: chairing of meeting 1 to 4 2 4 1
Teamworking & culture:
a)Inclusion of relevant team
members
1 to 4 2 2 2
b) Team Sociability 1 to 4 1 3 2
c) Mutual respect 1 to 4 2 4 2
d) tension and conflict 0 to −4 0 0 −1
Personal development & training 1 to 3 1 3 2
Infrastructure for meetings
Meeting venue 1 to 4 2 3 3
Technology & equipment 2 to 9 7 9 5
Meeting organisation and
logistics
Preparation prior to meetings:
a) agenda 1 to 3 3 3 2
b) Prioritisation of complex cases 1 to 4 1 2 1
Organisation/admin in MDM
a) patient notes
1 to 4 3 3 2
b) Case presentation 1 to 3 2 3 1
Clinical decision making
Patient-centred care 1 to 4 1 3 2
Treatment plans 1 to 4 2 4 2
Total rating 11-58 33 50 29Analysis
Quality ratings for each characteristic are presented in
their unstandardized form and are summed to provide an
overall score out of 58 (Table 2). The ratings for all charac-
teristics except teamworking: presence of tension/conflict
were standardised to the same scale and either presented
on a scale of 1–4 or dichotomised (very poor/poor vs.
good/very good) to enable visual comparison of variability
in quality within and between teams. Rating of the presence
of tension/conflict is not presented graphically as the scale
was not compatible.
Feasibility and inter-rater reliability
Feasibility was estimated by collecting data on the time
taken to complete observational assessments. Inter-rater
reliability was assessed by comparing the ratings of the
research team with those of two independent observers:
one oncology specialist registrar and one post-doctoral
research psychologist. Intraclass correlation coefficients
were calculated (two-way mixed models with measures
of absolute agreement). 95% confidence intervals arestandardized scores
Team Total number
of teams
‘very good’
4 5 6 7 8 9 10
core (see Table 1 for criteria)
1 2 2 4 4 4 4 6
3 2 2 3 3 3 2 1
4 2 3 3 2 4 4 3
4 3 2 3 1 4 2 2
4 2 2 3 2 4 4 4
0 0 −1 0 −1 0 −1 6
2 2 1 1 2 2 2 1
1 2 3 4 3 4 3 2
3 3 7 7 6 9 7 2
3 2 3 3 3 3 2 7
1 2 2 2 2 2 1 0
2 2 3 3 3 3 3 0
3 2 2 2 2 3 2 3
2 3 2 2 1 2 2 0
4 1 3 1 2 3 3 2
37 30 36 41 35 50 40
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were analysed using SPSS v.15.0 for windows.
Results
Criteria for assessing MDM quality
The quality criteria and methods for assessing each charac-
teristic are summarized in Table 1.
Acceptability and team meeting characteristics
Presence of an observer and videocamera in MDT meetings
was acceptable to team members and feasible to imple-
ment: it caused no delay or interruption to the usual flow
of meetings. Interviews with team members confirmed all
meetings had been typical: the presence of the researcher
and camera had negligible impact on team member
behaviour.
Meetings ranged in size from having 10 to 45 core and
extended members present (median 16 members). The lar-
gest MDT meeting was a network-wide meeting comprising
three local MDTs; all others comprised one local MDT.
The average meeting length was 53minutes (range: 25–86
minutes) and teams discussed an average of 13 patients
(range: 6–21 patients). Each patient was discussed for an
average of 4.5 minutes (range 3–9 minutes).
Variation in team performance between teams
There was wide diversity in ratings between teams across
all characteristics. Total scores (out of a possible 59)
ranged from 29 (team 3) to 50 (teams 2 and 9; Table 2).
Only one team (Team 3) failed to achieve ‘very good’
criteria for at least one characteristic. The quality of
teamwork in this team was particularly poor in relation
to chairing (the chair allowed long pauses in discussions
and did not explicitly confirm treatment plans before
moving onto the next case); prioritisation of the agenda
(9/14 cases discussed were rated as having too much
time spent on them as key information or results were
missing, or because relevant team members, for example
the oncologist, were absent); and presentation of clinical
information (case presentations were unprepared and
unstructured, time was spent searching for relevant
information for most cases). In contrast, Teams 2 and 9
met ‘very good’ criteria for 9 out of the 15 characteristics.
These teams demonstrated: optimal chairing (by ensuring
discussions remained focused and clearly articulating
treatment plans); inclusion of all relevant team members
in discussions (most other teams, although not always
dominated by one or two members, particularly lacked con-
tribution from the clinical nurse specialist or any other
nurses); explicit use of the meeting for professional develop-
ment (a well prepared, informative discussion about a wait-
ing times breach resulting in clear actions); optimal venue
and technology (a spacious purpose-built room; core
team seated in horseshoe formation enabling sight ofimaging/pathology and each other. Picture Archiving
and Communications System (PACS) and multiple
screens facilitated viewing of current and retrospective
pathology and radiological imaging); circulation of a
comprehensive agenda prior to meetings (including
patient ID and demographics, all previous relevant
history, tests undertaken/results, reason for MDT dis-
cussion, and space for MDT recommendation to be
inserted).Variation in team performance within teams
Some internal consistency within teams was evident:
MDTs performing well in one domain tended to perform
well in other domains (and vice versa, Figure 1). Eight
out of the 10 teams had the same rating (either ‘very
good/good’ or ‘very poor/poor’) for at least three of the
four domains of teamworking. The internal consistency
was most evident in teams performing at either end of
the spectrum: Team 3 received consistently poor ratings
across all characteristics with three ‘very poor’ ratings
and no ‘very good’ ratings, and teams 2 and 9 received 9
‘very good’ ratings and had no ‘very poor’ ratings of
quality for any characteristic (Table 2).Characteristics of effectiveness most and least likely to be
achieved
Teams were most likely to achieve ‘very good’ ratings for:
administrative preparation (a comprehensive agenda),
membership/attendance (all core team members or dep-
uties present for whole meeting), and tension/conflict (no
tension or conflict in meetings) (Table 2, Figure 2). Teams
were least likely to achieve ‘very good’ ratings for: patient-
centredness of case discussions and prioritisation of cases
on the agenda. No teams were observed to explicitly con-
sider patient-centred factors in all patient discussions: most
teams considered patient-based factors in less than half of
cases, mostly comprising demographic information rather
than holistic needs or preferences. There was no attempt by
any team to use the agenda to prioritise the order of case
discussions to ensure appropriate time was spent discussing
complex cases. In all teams at least some cases were judged
as being discussed for too little or too much time based on
their complexity.Feasibility and inter-rater reliability
Completion of assessments required 93 minutes on average
(range: 45–160 minutes). There was no consistent differ-
ence in time taken by different observers; instead the time
taken was associated with meeting length, averaging be-
tween 1.25 and 2 times the meeting length. There was a
trend for assessments to take longer initially (average 2
times length of meeting) compared to the final few teams
observed (average 1.25 times length of meeting).
Figure 1 Quality of teamworking across the four domains of teamworking.
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least 0.50 (and up to 0.92) were achieved for all except
two characteristics of effective teamworking: the absence
of tension/conflict (ICC = 0.10) and evidence of treat-
ment planning (ICC = 0.32; Table 3).
Discussion
We have developed a novel, observational measure for
assessing quality in cancer MDT meetings. The quality
criteria are calibrated against ‘effectiveness’ as defined by
consensus from over 2000 MDT members, and measure
quality in relation to 15 aspects of observable activity in
MDT meetings. Our preliminary study has shown that in-
dependent observation of MDT meetings is acceptable to
teams and feasible to conduct. Whilst only a small number
of teams participated in this pilot study, the application of
the measure highlighted wide diversity in the quality of
teamworking across the range of characteristics measured.
Teams typically performed well in terms of the adminis-
trative preparation for meetings and having the appropri-
ate team members in attendance. They performed less
well in relation to spending adequate time discussing cases
(requiring case prioritisation on the agenda), and havingFigure 2 Variation in quality of team performance according to charapatient-centred case discussions. Both of these aspects of
MDT function require additional preparation time, either
in relation to compiling and assessing case information to
determine their complexity, and/or additional time with
patients to comprehensively assess their history, needs and
wishes. The importance of undertaking regular assessment
of patients' needs and preferences (now referred to as
holistic needs assessment [21]) was highlighted in the
NICE guidance for improving supportive and palliative
care [22] and generally it is expected Clinical Nurse
Specialists (CNS) should lead this. Ensuring patient-led de-
cision making is fostered in the MDT meetings, where
patients are not present, is challenging due to the time
pressures of meetings and requires further attention.
Nevertheless if the opportunity is not grasped for informa-
tion to be obtained and shared with the wider team at the
earliest opportunity it may fail to impact on decision
making, or may cause avoidable delays to treatment [9,10].
In this study, few nurses contributed to case discussions
which may at least in part explain the lack of patient-based
information discussed. Similar findings have been reported
elsewhere [23]. Although responsibility for ensuring that
recommendations are patient-centred rests with the wholecteristic of effective teamworking.
Table 3 Inter-rater reliability of ratings across three independent observers
Rating Scale domains Intraclass correlation coefficient (95% confidence interval) Significance (p)
THE TEAM
Attendance n/a – rating based on in-vivo factual information
Leadership: chairing of the meeting 0.58 (−0.37 to 0.90) 0.07
Teamworking & culture:
a) Inclusion of all relevant team members 0.68 (0.07 to 0.92) 0.02
b) Team sociability 0.52 (−0.56 to 0.89) 0.10
c) Mutual respect between participants 0.72 (0.21 to 0.93) 0.01
d) Tension/conflict 0.10 (−0.92 to 0.73) 0.40
Personal development and training 0.74 (0.23 to 0.93) 0.01
INFRASTRUCTURE FOR MEETINGS
Meeting venue 0.92 (0.76 to 0.98) <0.001
Technology & equipment 0.92 (0.76 to 0.98) <0.001
MEETING ORGANISATION AND LOGISTICS
Preparation prior to meetings:a) agenda 0.55 (−0.13 to 0.87) 0.04
b) prioritisation of complex cases n/a rated by one observer only
Organisation/admin during meetings:a) patient notes 0.47 (−0.27 to 0.85) 0.07
b) case presentation 0.74 (0.16 to 0.94) 0.01
CLINICAL DECISION-MAKING PROCESS
Patient-centred care 0.77 (0.24 to 0.95) 0.01
Treatment Plan 0.32 (−0.84 to 0.83) 0.23
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in MDT discussions may be warranted.
This pilot study was aimed at determining ‘proof of
concept’ and has demonstrated that it is acceptable and
feasible to measure complex aspects of team behaviour
and activities such as leadership, teamworking and deci-
sion-making. The calibration of quality criteria against
characteristics of effectiveness agreed by a large sample
of MDT members, in addition to using available evi-
dence and expert input, ensured content validity. Fur-
thermore, most characteristics were measured reliably in
the hands of different observers. There was low agree-
ment in ratings for the presence of tension/conflict and
the clarity of treatment recommendations which may be
related to level of clinical experience. The quality criteria
require refinement to increase their reliability or it may
be necessary for observers to have relevant clinical ex-
perience for the ratings of these aspects of teamworking
to be valid.
Further testing is required with more teams and other
tumour types. Only one meeting was assessed per team
which may not have adequately represented their team-
working. Team members confirmed that the filmed
meetings were typical of their usual meetings in all cases,
but some aspects of teamworking may have been more
reliably rated longitudinally. This may be particularly im-
portant where behaviour or performance receives a poorrating. Furthermore, the teams volunteered through their
participation in another study. It is necessary to test this
method of observational assessment with other teams to
further confirm its acceptability. Validation of ratings
against other subjective and objective outcomes (such as
team member assessments of their own performance,
clinical outcomes, peer review data & national patient
experience data) will be important to further define the
characteristics of effective teamworking. The current design
of the tool, based upon rating case-by-case, enhanced
objectivity of ratings but was time consuming and is likely
to require simplification to have clinical as well as research
utility. Together with further validation, it may be desirable
to develop quality criteria for other characteristics of MDM
effectiveness. In particular this could include other aspects
of case discussions such as presentation of nationally agreed
minimum datasets for radiology, pathology and clinical
data; and adherence to relevant nationally and locally agreed
protocols. Such assessment may require observers with
clinical expertise, at least for assessment of these aspects of
team functioning.
The variation in quality of teamworking we report
reinforces the need to provide teams with appropriate
assessment tools, resources and training to optimise their
performance. Indeed 85% of MDT members that
responded to the UK national survey agreed MDTs need
performance measures [18].
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The preliminary testing of MDT-OARS indicates this could
be a useful component of MDT assessment, alongside other
measures of the quality of patient care provided by MDTs
including peer review and patient experience surveys.
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